News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Información sobre la transición de los ensayos clínicos a CTIS
Only 7 months left for the transition of all Clinical Trials to CTIS
International · EU projects
The deadline for transitioning clinical trials to CTIS ends on January 30, 2025. Studies continuing…
Partners - Sermes CRO
Fachada del edificio de las oficinas de Almirall
Almirall and the Centre for Genomic Regulation (CRG) Advance Research on Atopic Dermatitis
Healthcare · Access to innovation · Rare diseases
The research objectives of this collaboration include the characterization of experimental models…
Partners - Almirall
Jp
Biobide at the 51st Annual Meeting of the Japanese Society of Toxicology
Healthcare · Climate change · Agrifood · Industrial biotechnology · International · Corporate
Don't miss us at the 51st Annual Meeting of the Japanese Society of Toxicology!
Partners - Biotechnology Assets
Paciente afectado por artritis séptica
BCN HEALTH publishes a study evaluating the use of resources and medical costs of septic arthritis in Spain
Healthcare · Rare diseases
The objective of this study was to review the characteristics of patients admitted with septic…
Partners - BCN Health
Asabys Partners
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead candidate into clinical development in neurological diseases
Healthcare · Access to innovation · Financing
Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6…
Partners - Asabys Partners
Oryzon_AseBio
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
Corporate
All resolutions were approved. Additional resolution to increase capital for up to 100 million…
Partners - Oryzon Genomics
Profesional de laboratorio manipulando máquinas en la instalaciones de Hipra
The European authority HERA visits HIPRA for its productive capacity in the face of future pandemic
Healthcare · Access to innovation · Drug discovery · Industrial biotechnology
The top leadership team from HERA (Health Emergency Preparedness and Response), the European…
Partners - HIPRA HUMAN HEALTH S.L.U.
Una chica apoyada en una pared
Oryzon announces presentation of final data from PORTICO, vafidemstat’s global Phase IIb trial in Borderline Personality Disorder, at the 37th ECNP annual conference
Healthcare · Access to innovation · Rare diseases · Advanced therapies
Seleccionada para presentación oral. La conferencia se celebrará en Milán del 21-23 de septiembre…
Partners - Oryzon Genomics
Investigación en biotecnología
Overcoming Challenges in the Current Biotech Landscape
Biotech entrepreneurs have experienced a demanding drug development environment in the last 24…